Metabolic syndrome common in people with psychotic disorders, particularly in users of high potency antipsychotics

被引：0
|
作者：
Suivisaari, Jaana [1 ]
机构：
[1] Natl Publ Hlth Inst, Dept Mental Hlth & Alcohol Res, Mannerheimintie 166, FIN-00300 Helsinki, Finland
来源：
EVIDENCE-BASED MENTAL HEALTH | 2008年 / 11卷 / 02期
基金：
芬兰科学院;
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：62 / 62
页数：1
相关论文
共 50 条
  • [21] Preventing the Development of Metabolic Syndrome in People with Psychotic Disorders-Difficult, but Possible: Experiences of Staff Working in Psychosis Outpatient Care in Sweden
    Bergqvist, Anette
    Karlsson, Maria
    Foldemo, Anniqa
    Wardig, Rikard
    Hultsjo, Sally
    ISSUES IN MENTAL HEALTH NURSING, 2013, 34 (05) : 350 - 358
  • [22] The incidence of metabolic syndrome and its reversibility in patients with psychotic disorders followed for one year
    Schorr, S.
    Slooff, C. J.
    Bruggeman, R.
    Taxis, K.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S435 - S436
  • [23] Prevalence and correlates of metabolic syndrome and its components in adults with psychotic disorders in Eldoret, Kenya
    Kwobah, Edith
    Koen, Nastassja
    Mwangi, Ann
    Atwoli, Lukoye
    Stein, Dan J.
    PLOS ONE, 2021, 16 (01):
  • [24] Metabolic syndrome among persons with schizophrenia and other psychotic disorders in a general population survey
    Suvisaari, Jaana M.
    Saarni, Samuli I.
    Perala, Jonna
    Suvisaari, Janne V. J.
    Harkanen, Tommi
    Lonnqvist, Jouko
    Reunanen, Antti
    JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (07) : 1045 - 1055
  • [25] Persistent Low Rates of Treatment of Metabolic Risk Factors in People With Psychotic Disorders: A PHAMOUS Study
    Bruins, Jojanneke
    Pijnenborg, Gerdina H. M.
    van den Heuvel, Edwin R.
    Visser, Ellen
    Corpeleijn, Eva
    Bartels-Velthuis, Agna A.
    Bruggeman, Richard
    Jorg, Frederike
    JOURNAL OF CLINICAL PSYCHIATRY, 2017, 78 (08) : 1117 - +
  • [26] THE ROLE OF HIGH POTENCY CANNABIS USE AND PSYCHOSIS GENETIC LIABILITY IN MODERATING THE RISK FOR ONSET OF PSYCHOTIC DISORDERS
    Diforti, M.
    Murray, Robin
    SCHIZOPHRENIA BULLETIN, 2011, 37 : 50 - 50
  • [27] Comparison of clinical outcomes associated with long-acting injectable antipsychotics in people with psychotic disorders: an electronic case register study
    Patel, Rashmi
    Chesney, Edward
    Taylor, Matthew
    Taylor, David
    McGuire, Philip
    LANCET, 2017, 389 : 77 - 77
  • [28] Psychotic disorders and electrocardiogram abnormalities in the acute psychiatric setting: more than the metabolic syndrome alone
    Philip, Aaron Benjamin
    Dratcu, Luiz
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2021, 25 (01) : 103 - 105
  • [29] The incidence of metabolic syndrome and its reversibility in a cohort of patients with psychotic disorders followed for one year
    Taxis, Katja
    Schorr, Susanne G.
    Slooff, Cees J.
    Bruggeman, Richard
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2008, 17 : S258 - S258
  • [30] Metabolic and clinical profiles of young people with mood or psychotic disorders who are prescribed metformin in an inpatient setting
    Wilson, Chloe
    Carpenter, Joanne
    Park, Shinho
    McHugh, Catherine
    Scott, Elizabeth M.
    Hickie, Ian B.
    AUSTRALASIAN PSYCHIATRY, 2022, 30 (06) : 689 - 693
12345